Universal-Beteiligungs- und Servicegesellschaft’s BioMarin Pharmaceuticals BMRN Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.91M	Sell	50,427 -216	-0.4%	-$11.8K	﹤0.01%	1152
2026 Q1	$2.89M	Buy	50,643 +3,551	+8%	+$207K	0.01%	1108
2025 Q4	$2.82M	Sell	47,092 -49,161	-51%	-$2.68M	﹤0.01%	1132
2025 Q3	$5.21M	Buy	96,253 +2,564	+3%	+$147K	0.01%	855
2025 Q2	$5.15M	Sell	93,689 -68,118	-42%	-$4.01M	0.01%	825
2025 Q1	$11.4M	Buy	161,807 +2,807	+2%	+$189K	0.02%	528
2024 Q4	$10.5M	Buy	+159,000	New	+$10.7M	0.02%	533

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's BMRN Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its BioMarin Pharmaceuticals (BMRN) stake by 0.43% in Q2 2026, selling an estimated $11.8K and leaving 50,427 shares worth $2.91M. The position accounts for ﹤0.01% of the portfolio, ranked #1152.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in BMRN in Q4 2024 and has held it in 7 quarters since. The position peaked at $11.4M in Q1 2025. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

Universal-Beteiligungs- und Servicegesellschaft held 50,427 shares of BioMarin Pharmaceuticals worth $2.91M as of Q2 2026.
Universal-Beteiligungs- und Servicegesellschaft sold 216 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $11.8K.
BioMarin Pharmaceuticals made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1152 holding.
Universal-Beteiligungs- und Servicegesellschaft first reported a position in BioMarin Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
Universal-Beteiligungs- und Servicegesellschaft's BioMarin Pharmaceuticals position peaked at $11.4M in Q1 2025.
565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.